1
|
Tan S, Choong DJ, Tan E. A systematic review of the management of eosinophilic dermatosis of hematological malignancy. Int J Dermatol 2024; 63:1164-1171. [PMID: 38727148 DOI: 10.1111/ijd.17221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/25/2024] [Revised: 04/12/2024] [Accepted: 04/14/2024] [Indexed: 09/01/2024]
Abstract
Eosinophilic dermatosis of hematologic malignancy (EDHM) is a cutaneous manifestation seen in patients with hematoproliferative and lymphoproliferative disorders, most commonly chronic lymphocytic leukemia. This systematic review aimed to summarize the therapeutic interventions of EDHM. A comprehensive search yielded 71 studies, predominantly case reports and series. The most frequently reported modalities were systemic and topical corticosteroids, as well as treatment of the underlying malignancy. Responses to these treatments varied. Targeted therapies, including dupilumab and omalizumab, showed promise, as did other modalities such as montelukast, dapsone, doxycycline, and phototherapy. Higher-quality studies should be conducted to facilitate higher-quality management recommendations for EDHM.
Collapse
Affiliation(s)
- Stephanie Tan
- Sir Charles Gairdner Hospital, Nedlands, WA, Australia
| | - Dean Jeremy Choong
- Western Australian Faculty, The Australasian College of Dermatologists, St. Leonards, NSW, Australia
- Fiona Stanley Fremantle Hospital Group, Murdoch, WA, Australia
| | - Ernest Tan
- Sir Charles Gairdner Hospital, Nedlands, WA, Australia
- Western Australian Faculty, The Australasian College of Dermatologists, St. Leonards, NSW, Australia
| |
Collapse
|
2
|
Carlesimo M, Narcisi A, Rossi A, Saredi I, Orsini D, Pelliccia S, Aloe Spiriti M, Mari E, Cox M. Cutaneous manifestations of systemic non-Hodgkin lymphomas (NHL): study and review of literature. J Eur Acad Dermatol Venereol 2013; 28:133-41. [DOI: 10.1111/jdv.12201] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2013] [Accepted: 05/17/2013] [Indexed: 01/01/2023]
Affiliation(s)
| | - A. Narcisi
- Department of Dermatology; NESMOS Department
| | - A. Rossi
- Department of Dermatology; University of Rome “Sapienza”; Rome Italy
| | - I. Saredi
- Department of Dermatology; NESMOS Department
| | - D. Orsini
- Department of Dermatology; NESMOS Department
| | - S. Pelliccia
- Department of Haematology; Sant'Andrea Hospital; University of Rome “Sapienza”
| | - M.A. Aloe Spiriti
- Department of Haematology; Sant'Andrea Hospital; University of Rome “Sapienza”
| | - E. Mari
- Department of Dermatology; NESMOS Department
| | - M.C. Cox
- Department of Haematology; Sant'Andrea Hospital; University of Rome “Sapienza”
| |
Collapse
|
3
|
Shaik Y, Sabatino G, Maccauro G, Varvara G, Murmura G, Saggini A, Rosati M, Conti F, Cianchetti E, Caraffa A, Antinolfi P, Pandolfi F, Potalivo G, Galzio R, Conti P, Theoharides T. IL-36 Receptor Antagonist with Special Emphasis on IL-38. Int J Immunopathol Pharmacol 2013; 26:27-36. [DOI: 10.1177/039463201302600103] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
IL-36 is another family member of IL-1 and induces the production of proinflammatory cytokines and activates MAPK and NFκB pathways. IL-36 is a common mediator of innate and adaptive immune response and is inhibited by IL-36 receptor antagonist (RA). IL-36RA acts on IL-36 receptor ligand which exerts proinflammatory effect in vivo and in vitro. IL-38 binds to IL-36 receptor as does IL-36RA and has similar biological effects on immune cells. IL-38 is also a member of IL-1 cytokine and shares some characteristics of IL-1RA, binding the same IL-1 receptor type I. IL-38 plays a role in the pathogenesis of inflammatory diseases, exerting protective effect in some autoimmune diseases. Both IL-38 and IL-36RA have an anti-inflammatory biological effect, however in some cases have contrary effects.
Collapse
Affiliation(s)
- Y. Shaik
- Department of Medicine, Boston University School of Medicine, Boston, MA, USA
| | - G. Sabatino
- Neonatology Division, University of Chieti, Italy
| | - G. Maccauro
- Department of Orthopedics, Catholic University of Rome, Italy
| | - G. Varvara
- Dental School, University of Chieti-Pescara, Italy
| | - G. Murmura
- Dental School, University of Chieti-Pescara, Italy
| | - A. Saggini
- Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
| | - M. Rosati
- Gynecology Division, Pescara Hospital, Pescara, Italy
| | - F. Conti
- Gynecology Division, Pescara Hospital, Pescara, Italy
| | - E. Cianchetti
- Ortona Hospital, University of Chieti-Pescara, Italy
| | - A. Caraffa
- Orthopeadics Division, University of Perugia, Perugia Italy
| | - P. Antinolfi
- Orthopeadics Division, University of Perugia, Perugia Italy
| | - F. Pandolfi
- Department of Internal Medicine, Catholic University of the Sacred Heart, Rome, Italy
| | - G. Potalivo
- Orthopeadics Division, University of Perugia, Perugia Italy
| | - R. Galzio
- Department of Health Sciences, University of L ‘Aquila, Italy
| | - P. Conti
- Immunology Division, Department of Experimental and Clinical Sciences, University of Chieti, Italy
| | - T.C. Theoharides
- Department of Pharmacology and Experimental Therapeutics, Biochemistry and Internal Medicine Tufts University School of Medicine, Tufts-New England Medical Center, Boston, MA, USA
| |
Collapse
|
4
|
Tetè S, Varvara G, Murmura G, Saggini A, Maccauro G, Rosati M, Cianchetti E, Tripodi D, Toniato E, Fulcheri M, Caraffa A, Antinolfi P, Pandolfi F, Potalivo G, Conti P, Theoharides T. Impact of Immunity in Autism Spectrum Disorders. EUR J INFLAMM 2013. [DOI: 10.1177/1721727x1301100103] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Autism spectrum disorders (ASDs) are childhood psychopathologies characterized by having difficulties in social interaction, verbal and non-verbal communication as well as sensor motor movements. Evidence suggests that in ASDs environmental toxicant exposure, genetic and mitochondrial dysfunction are involved associated with abnormal immune response with allergic problems and elevated serum IgE. ASDs present the major cytokine and chemokine dysfunction in CNS and is mediated by an increase of pro-inflammatory cytokine levels in the brain, such as TNF, IL-1, IFN-γ, IL-6, IL-8 and others. Mast cells, which are also implicated in ASDs, are worsened by stress and produce proinflammatory cytokines and can be stimulated by neurotensin in the brain and gut, contributing also to the inflammatory response. However, the exact etiology of ASDs remains largely unknown.
Collapse
Affiliation(s)
- S. Tetè
- Dental School, University of Chiet-Pescarai, Chieti, Italy
| | - G. Varvara
- Dental School, University of Chiet-Pescarai, Chieti, Italy
| | - G. Murmura
- Dental School, University of Chiet-Pescarai, Chieti, Italy
| | - A. Saggini
- Dermatology Department, University Tor Vergata, Rome, Italy
| | - G. Maccauro
- Orthopedics Division, Università Cattolica, Rome, Italy
| | - M. Rosati
- Gynecology Division, Pescara Hospital, Italy
| | - E. Cianchetti
- Department of Surgery, Ortona ASL Hospital, Ortona, Italy
| | - D. Tripodi
- Dental School, University of Chiet-Pescarai, Chieti, Italy
| | - E. Toniato
- Immunology Division, Medical School, University of Chieti-Pescara, Italy
| | - M. Fulcheri
- Psychology School, University of Chieti-Pescara, Italy
| | - A. Caraffa
- Orthopeadics Division, University of Perugia, Italy
| | - P. Antinolfi
- Orthopeadics Division, University of Perugia, Italy
| | - F. Pandolfi
- Department of Medicine, Catholic University of Rome, Rome, Italy
| | - G. Potalivo
- Orthopeadics Division, University of Perugia, Italy
| | - P. Conti
- Immunology Division, Medical School, University of Chieti-Pescara, Italy
| | - T.C. Theoharides
- Internal Medicine and Biochemistry, Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Molecular Physiology and Pharmacology, Tufts University School of Medicine and Drug Discovery Laboratory, Tufts-New England Medical Center, Boston, MA, USA
| |
Collapse
|